Results 11 to 20 of about 57,525 (156)

Acquired hemophilia in a patient with SARS-CoV-2 infection; a case report [PDF]

open access: yesJournal of Nephropharmacology, 2022
Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed.
Ali Hajigholami   +3 more
doaj   +1 more source

The role of hemostatic changes in the pathogenesis of diabetic retinopathy

open access: yesJournal of Education, Health and Sport, 2022
Introduction: The paper presents the results of the hemostasis system of rats with experimental diabetic retinopathy. Material and methods: Experimental studies were performed on white Wistar rats, which were divided into 2 groups: 1st group – intact
Nataliya Preys, Ivan Savytskyi
doaj   +1 more source

The partial thromboplastin (cephalin) time test [PDF]

open access: yesJournal of Clinical Pathology, 1972
Nine partial thromboplastin (cephalin) reagents have been compared in a parallel investigation of groups of patients on `long-term' anticoagulants, a group with moderate haemophilia, and patients on heparin infusion. Results with the seven commercial reagents and a human cephalin extract have been correlated with those of a specially ...
L, Poller, J M, Thomson
openaire   +2 more sources

Hemostatic activities of methanol leaf extracts of Croton megalocarpus Hutch and Lantana camara Linn

open access: yesJournal of Advanced Biotechnology and Experimental Therapeutics, 2021
Hemostasis is the natural mechanism by which blood is kept in a fluid state in circulation with the ability to cause clotting at an injury site. The effects of Croton megalocarpus Hutch and Lantana camara Linn plants leaves on blood coagulation has not ...
Hezron Mutisya Muindi   +2 more
doaj   +1 more source

Perbedaan Pengaruh Pemberian Infus HES Dengan Berat Molekul 40 kD dan 200 kD Terhadap Plasma Prothrombin Time dan Partial Thromboplastin Time Kajian Pada Pasien Dengan Perdarahan Sampai 20% Estimated Blood Volume

open access: yesJAI (Jurnal Anestesiologi Indonesia), 2009
Latar belakang: Pasien dengan operasi besar yang beresiko terjadi perdarahan semakin meningkat setiap tahun. HES dengan berat molekul besar mempertahankan hemodinamik lebih baik tetapi mengganggu faktor koagulasi.
Hari Hendriarto Satoto   +2 more
doaj   +1 more source

Biological evaluation of the effect of sugammadex on hemostasis and bleeding [PDF]

open access: yesKorean Journal of Anesthesiology, 2015
BackgroundNotification of sugammadex has been supplemented with a section on hemostasis, including a longer clotting time in the first minutes following injection, without any documented clinical consequences.
Julien Raft   +4 more
doaj   +1 more source

Performance Evaluation of Four Activated Partial Thromboplastin Time Reagents

open access: yesPharmacology and Clinical Pharmacy Research, 2018
Activated Partial Thromboplastin Time (APTT) is a hematological examination to identify hemostatic abnormalities. This study aimed to compare the performance evaluation of four APTT reagents, i.e., CK Prest, Pathromtin SL, Actin SL, and Cephascreen.
Peppi Z. Yuzaqi   +2 more
doaj   +1 more source

Aromatic Amines Exert Contrasting Effects on the Anticoagulant Effect of Acetaldehyde upon APTT

open access: yesAdvances in Hematology, 2014
The pharmacological effects of amphetamine, procaine, procainamide, DOPA, isoproterenol, and atenolol upon activated partial thromboplastin time in the absence and presence of acetaldehyde have been investigated.
La'Teese Hall   +2 more
doaj   +1 more source

Association of Abnormal Coagulation Tests in Dengue Fever with Clinical Outcomes of The Patients

open access: yesPakistan Armed Forces Medical Journal, 2022
Objective: To assess the coagulation test abnormalities (prothrombin time, activated partial thromboplastin time and fibrin degradation products) in dengue fever patients and its impact on clinical outcomes of the patient.
Zareen Irshad   +5 more
doaj   +1 more source

Prothrombine and activated partial thromboplastin time are prolonged in hepatic cirrhosis

open access: yesUniversa Medicina, 2016
Background Chronic hepatitis and hepatic cirrhosis are chronic liver diseases that cause disorders of liver function, such as the formation of platelets and coagulation factors (prothrombin time/PT and activated partial thromboplastin time/APTT ...
Edward Kurnia Setiawan Limijadi   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy